secwatch / observer
8-K filed May 22, 2026, 4:19 PM ET ticker NEO CIK 0001077183
other confidence high sentiment neutral materiality 0.30

NeoGenomics stockholders approve 5M share increase to 2023 equity plan, elect all director nominees

NEOGENOMICS INC

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.99

NEOGENOMICS INC shareholders approved Proposal No. 2: The approval, on an advisory basis, of the compensation paid to the Company’s Named Executive Officers, as identified in the proxy statement for the Annual Meeting. at the 2026-05-21 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2026-05-21
Exact text from the filing
Proposal No. 2: The approval, on an advisory basis, of the compensation paid to the Company’s Named Executive Officers, as identified in the proxy statement for the Annual Meeting. The advisory approval received an affirmative vote of a majority of the votes cast by stockholders as follows: Number of Votes Outstanding % Voted % For 91,781,833 70.52% 83.19% Against 18,534,236 14.24% 16.80% Abstentions 56,118 0.04% 0.05% Broker Non-Votes 6,257,933
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.99

NEOGENOMICS INC shareholders approved Proposal No. 1: The election of Lynn A. Tetrault, Dr. Marjorie C. Green, Dr. Neil Gunn, Stephen M. Kanovsky, Michael A. Kelly, John P. Kenny, David B. Perez, Felicia Williams and Anthony P. Zook to serve as members of the Board of Directors until the next succeeding annual meeting of stockholders or at the 2026-05-21 meeting.

Proposal
director election
Outcome
passed
Meeting
2026-05-21
Exact text from the filing
Proposal No. 1: The election of Lynn A. Tetrault, Dr. Marjorie C. Green, Dr. Neil Gunn, Stephen M. Kanovsky, Michael A. Kelly, John P. Kenny, David B. Perez, Felicia Williams and Anthony P. Zook to serve as members of the Board of Directors until the next succeeding annual meeting of stockholders or until his or her successor has been duly elected and qualified. The stockholders elected the nine directors by the following votes: Votes For Votes Against Abstentions Broker Non-Votes Lynn A. Tetrault 105,727,863 3,367,912 1,276,412 6,257,933 Dr. Marjorie C. Green 109,519,041 778,682 74,464 6,257,933 Dr. Neil Gunn 107,351,592 2,945,140 75,455 6,257,933 Stephen M. Kanovsky 109,295,532 973,974 102,681 6,257,933 Michael A. Kelly 104,709,238 5,604,891 58,058 6,257,933 John P. Kenny 110,028,235 268,748 75,204 6,257,933 David B. Perez 106,880,533 3,425,136 66,518 6,257,933 Felicia Williams 109,486,148 792,263 93,776 6,257,933 Anthony P. Zook 109,656,654 657,836 57,697 6,257,933
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.99

NEOGENOMICS INC shareholders approved Proposal No. 3: The approval of the Amendment (Second Amendment of the 2023 Equity Incentive Plan), as identified in the proxy statement for the Annual Meeting. at the 2026-05-21 meeting.

Proposal
equity plan
Outcome
passed
Meeting
2026-05-21
Exact text from the filing
Proposal No. 3: The approval of the Amendment, as identified in the proxy statement for the Annual Meeting. The stockholders approved the proposal by the following vote: Number of Votes Outstanding % Voted % For 108,010,493 82.99% 97.90% Against 2,308,922 1.77% 2.09% Abstentions 52,772 0.04% 0.04% Broker Non-Votes 6,257,933
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.99

NEOGENOMICS INC shareholders approved Proposal No. 4: The ratification of the appointment of Deloitte & Touche LLP as the independent registered public accountant. at the 2026-05-21 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2026-05-21
Exact text from the filing
Proposal No. 4: The ratification of the appointment of Deloitte & Touche LLP as the independent registered public accountant. The stockholders approved the proposal by the following vote: Number of Votes Outstanding % Voted % For 116,103,093 89.21% 99.57% Against 494,869 0.38% 0.42% Abstentions 32,158 0.02% 0.02%
View on SEC.gov

550 shareholder votes filed in the last 30 days. Browse all shareholder votes →

NEOGENOMICS INC filing history →

Source: SEC EDGAR
accession 0001628280-26-037735
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.